glp 1 parkinson's disease Role of glucagon-like peptide-1 receptor agonists in Alzheimer's and disease | Journal of Biomedical Science Neuroprotective Actions of Glucagon-Like Peptide-1

As per this research, the primary treatment method is supplementation with vitamin B12

Additionally, the variability in individual responses to alcohol presents a challenge in understanding the relationship between ethanol consumption and depression

8 Conclusion, limitations, and future directions Numerous studies have shown that changes in microbial diversity and disturbances in microbiome composition can be linked to the onset of various diseases

Even a stroke is a form of cerebral ischemia whereby the reduced blood supply to the brain can initiate neurological diseases

Pooled analyses from trials such as SUSTAIN-6 and LEADER reported reductions in albuminuria and slower declines in estimated glomerular filtration rates (eGFR), with pronounced benefits observed in those with lower baseline eGFR (41)